Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Saba Capital Management, L.P., identified as a ten-percent owner of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), reported dispositions totaling 303,392 shares valued at $4.2 million in an SEC Form 4 filing. The sales occurred on April 1 and April 2, 2026, at $13.87 per share. After the April 1 transactions Saba's direct holdings stoo…
Toast, Inc. General Counsel Brian R. Elworthy sold 3,664 shares of Class A common stock on April 2, 2026, for $26.187 per share, generating $95,949 in proceeds. The transaction follows a conversion of 10,045 restricted stock units on April 1, 2026, and comes as Toast shares trade close to their 52-week low. The company reported mixed fourth-quarter…
Immunovant Chief Executive Officer Eric Venker sold $342,854 of company stock on April 2, 2026, in two transactions. The sales followed a conversion of Capped Value Appreciation Rights into common shares on April 1, 2026. The stock trades near $24.50, up about 55% over the past year, while market analysis flags the shares as overvalued relative to …
Oklo Inc. (NASDAQ: OKLO) CEO Jacob DeWitte and his spouse Caroline Cochran sold a combined $10,069,852 of Class A common stock on April 1, 2026, through a series of transactions conducted under a Rule 10b5-1 plan adopted in March 2025. The trades occurred at prices between $48.41 and $51.20 per share. The company has seen a steep six-month decline …
Etsy Executive Chair Josh Silverman sold 6,074 shares on April 1, 2026, realizing roughly $298,023, while simultaneously receiving a substantial grant through vesting and exercising options. Analysts reacted to Etsy's recent results and strategic moves with a range of price targets and ratings, reflecting differing views on the company's trajectory…
Oklo Inc.'s Chief Financial Officer Richard Craig Bealmear sold 16,342 Class A shares on April 1, 2026, at $51.08 per share for proceeds of $834,749 and exercised options to acquire additional shares in early April. The transactions were reported on a Form 4 and implemented under a Rule 10b5-1 plan adopted in September 2025. The stock has been vola…
Peter Toth, Newmont’s Executive Vice President and Chief Sustainability & Development Officer, sold 3,000 shares of company stock on April 1, 2026, in a pre-arranged Rule 10b5-1 plan. The transaction totaled $339,270 and leaves Toth with 52,315 shares. Market commentary and analyst updates show mixed views on Newmont’s earnings power and exposure t…
Brenton Taylor, Executive Vice President of Operations and R&D at Sight Sciences, sold 2,869 shares on April 1, 2026, in a transaction disclosed on a Form 4. The sale, executed to meet tax obligations tied to vested restricted stock units, realized $10,615 at a weighted average price of $3.70 per share. Sight Sciences also reported fourth-quarter 2…
Sight Sciences President and CEO Paul Badawi disposed of 29,244 shares on April 1, 2026, raising $108,202 to cover the tax bill from vested restricted stock units. The transaction leaves Badawi with 6,151,156 shares, a total that includes unvested RSUs. The move comes as the stock trades below the sale range and after the company reported a Q4 2025…
Joby Aviation Chief Product Officer Eric Allison sold 9,350 shares of common stock on April 2, 2026, raising roughly $76,202 in proceeds. The sale followed the conversion of restricted stock units into common shares on April 1, 2026. Joby continues to advance its testing program, including Bay Area demonstration flights and flight tests of its FAA-…
Kristen N. Sieffert, President of Finance of America Companies Inc. (NASDAQ: FOA), carried out a series of equity transactions on April 1, 2026, including the sale of 750 Class A shares, the exercise of options for 84,469 shares at no cost, the sale of shares to satisfy tax obligations from settled restricted stock units, and the receipt of 72,674 …
Joby Aviation CFO Rodrigo Brumana sold 1,839 shares on April 2, 2026, for roughly $14,987, following an April 1 exercise of options on 5,045 shares at a $0 strike. The transactions occur as Joby begins FAA-conforming flight testing of aircraft N547JX and progresses toward Type Inspection Authorization and broader regulatory steps, while analysts is…
Limoneira CO's vice president, chief financial officer and treasurer, Gregory C. Hamm, disposed of 1,000 shares on April 2, 2026, in a transaction conducted under a Rule 10b5-1 plan. The sale came as the company reported a wider-than-expected adjusted loss in the first quarter of fiscal 2026, even as revenue exceeded forecasts. Limoneira's board ha…
Simon Frederic, a director at JFrog Ltd (NASDAQ: FROG), sold 79,999 ordinary shares across four transactions on April 1-2, 2026, generating roughly $3.9 million. The trades were carried out under a Rule 10b5-1 plan adopted in August 2025. The company has drawn attention from multiple analysts emphasizing its potential role in cybersecurity and AI, …
Analog Devices Chair and CEO Vincent Roche sold 10,000 shares on April 1, 2026, for roughly $3.18 million under a pre-arranged 10b5-1 trading plan and exercised options to acquire 10,000 additional shares the same day. The moves come as ADI shares have climbed 79% year-over-year and several analysts raised price targets after the company reported s…
Netflix Chief Financial Officer Spencer Adam Neumann sold 28,630 shares of common stock at $98 per share on April 2, 2026, in a transaction reported on a Form 4 filed with the SEC. On the same day he exercised options to acquire an equal number of shares at strike prices of $36.408 and $38.105, with the option exercise totaling $1,055,546. After th…
BioAge Labs Chief Medical Officer Paul D. Rubin sold 8,820 shares on April 1, 2026, for $17.81 per share, generating $157,084, and on the same day exercised options to acquire 8,820 shares at strike prices of $4.11 and $6.57, valued at $44,572. The stock has risen roughly 415% over the past year and currently trades near $17.50, while InvestingPro …
Viant Technology Inc. Chief Financial Officer Larry Madden executed two stock sales on April 1 and April 2, 2026, disposing of 17,541 shares of Class A common stock for roughly $194,417 under a 10b5-1 trading plan adopted on December 15, 2025. The transactions follow a quarter in which Viant reported better-than-expected revenue, earnings, and adju…
Teladoc Health Chief Accounting Officer Joseph Ronald Catapano sold 675 shares on April 2, 2026, after exercising options to acquire 2,083 shares on April 1. The sale, disclosed on a Form 4, leaves Catapano with 10,249 shares. The transaction occurs amid analyst upgrades, activist calls for a $200 million buyback and a new board appointment.
Maurice Sciammas, Executive Vice President for Worldwide Sales & Marketing at Monolithic Power Systems Inc (MPWR), sold 30 shares on April 1, 2026, for $1,116.44 per share, yielding $33,493. The sale was made under a Rule 10b5-1 trading plan adopted on November 19, 2025. After the transaction, Sciammas directly holds 178,644 shares and also control…
Moody's Corp President and CEO Robert Fauber sold 875 shares of company stock on April 1, 2026, for $437.77 per share, generating $382,662 in proceeds. He also exercised options to acquire 1,167 shares, representing $163,409 in acquired value, and now directly holds 75488.918 shares. The transactions were carried out under a Rule 10b5-1 trading pla…
Regeneron Pharmaceuticals Inc. director Arthur F. Ryan sold 96 shares of the company on April 1, 2026, for $77,727 under a pre-established Rule 10b5-1(c) plan. The trades were carried out at prices between $771.32 and $779.71. After the sale, Ryan directly holds 17,603 shares. The stock was trading at $761.85, close to its 52-week high of $821.11, …
Avalo Therapeutics CFO Christopher Ryan Sullivan sold 16,059 shares across April 1 and 2, 2026, under a pre-established 10b5-1 trading plan, realizing $270,593 in proceeds. The trades occurred as Avalo shares have posted substantial gains over the past year and in the prior week, while several analysts reiterated or set Buy ratings and price target…
Senior Vice President Paul Cunningham sold 1,000 shares of Cadence Design Systems Inc on April 1, 2026, at $280.19 per share under a Rule 10b5-1 trading plan. The transaction reduced his holdings to 128,586 shares. The sale occurs amid mixed indicators for the stock - robust fiscal results and strategic moves on one hand, and valuation metrics and …
MGIC Investment CEO Timothy J. Mattke sold 139,202 shares on April 2, 2026, generating roughly $3.6 million in proceeds under a pre-arranged Rule 10b5-1 plan. The company reported fourth-quarter 2025 earnings with EPS matching analyst forecasts at $0.75 but revenue of $298.65 million, falling $9.54 million short of expectations. Despite the sale, m…
